Phase 2 Trial of Avelumab in Combination with Gemcitabine in Advanced Leiomyosarcoma As a Second-Line Treatment (EAGLES, Korean Cancer Study Group UN18-09)
CANCER（2024）
Key words
avelumab,gemcitabine,leiomyosarcoma,survival,tumor-infiltrating lymphocytes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined